Caspase-8 and caspase-10 activate NF-κB through RIP, NIK and IKKα kinases

被引:50
作者
Shikama, Y [1 ]
Yamada, M [1 ]
Miyashita, T [1 ]
机构
[1] Natl Res Inst Child Hlth & Dev, Dept Genet, Setagaya Ku, Tokyo 1548567, Japan
关键词
apoptosis; caspases; NF-kappa B; death effector domain;
D O I
10.1002/eji.200324013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NF-kappaB regulates the expression of various genes involved in cell growth and differentiation, immune response and inhibition of apoptosis. Recently, some death effector domain (DED)-containing proteins, such as FADD and c-FILIP were reported to activate NF-kappaB. We previously reported that the prodomain-only isoforms of caspase-8 and -10 (PDCasp8/10), containing two DED motifs, could inhibit Fas-mediated apoptosis. Here, we demonstrate that these isoforms also activate NF-kappaB, implying this to be one of the mechanisms by which these polypeptides inhibit apoptosis. The GST pull-down assay revealed that, among upstream kinases that activate NF-kappaB, only NIK and RIP, but not RICK or IKKalpha/beta, could directly bind to PDCasp8/10. In addition, both modules of DED in PDCasp8/10 were required for these interactions as well as NIF-kappaB activation. Experiments using a kinase-dead mutant of IKKalpha and an RIP mutant lacking a kinase domain, both of which function as dominant-negative mutants for their wild-type counterparts, blocked PDCasp8/10-mediated NF-kappaB activation. Using small interfering RNA technology, we further demonstrate that the down-regulation of IKKalpha but not IKKbeta significantly inhibits PDCasp8-mediated NF-kappaB activation. Taken together, these results suggest that caspase-8 and -10 have roles in a non- or anti-apoptotic signaling pathway leading to NF-kappaB activation through RIP, NIK and IKKalpha.
引用
收藏
页码:1998 / 2006
页数:9
相关论文
共 41 条
[1]   Human ICE/CED-3 protease nomenclature [J].
Alnemri, ES ;
Livingston, DJ ;
Nicholson, DW ;
Salvesen, G ;
Thornberry, NA ;
Wong, WW ;
Yuan, JY .
CELL, 1996, 87 (02) :171-171
[2]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[3]   Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-κB [J].
Bertin, J ;
Nir, WJ ;
Fischer, CM ;
Tayber, OV ;
Errada, PR ;
Grant, JR ;
Keilty, JJ ;
Gosselin, ML ;
Robison, KE ;
Wong, GHW ;
Glucksmann, MA ;
DiStefano, PS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (19) :12955-12958
[4]   Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death [J].
Boldin, MP ;
Goncharov, TM ;
Goltsev, YV ;
Wallach, D .
CELL, 1996, 85 (06) :803-815
[5]   Activation of the NF-κB pathway by Caspase 8 and its homologs [J].
Chaudhary, PM ;
Eby, MT ;
Jasmin, A ;
Kumar, A ;
Liu, L ;
Hood, L .
ONCOGENE, 2000, 19 (39) :4451-4460
[6]   Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency [J].
Chun, HJ ;
Zheng, LX ;
Ahmad, M ;
Wang, J ;
Speirs, CK ;
Siegel, RM ;
Dale, MK ;
Puck, J ;
Davis, J ;
Hall, CG ;
Skoda-Smith, S ;
Atkinson, TP ;
Straus, SE ;
Lenardo, MJ .
NATURE, 2002, 419 (6905) :395-399
[7]   RAIDD is a new 'death' adaptor molecule [J].
Duan, H ;
Dixit, VM .
NATURE, 1997, 385 (6611) :86-89
[8]   In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains [J].
FernandesAlnemri, T ;
Armstrong, RC ;
Krebs, J ;
Srinivasula, SM ;
Wang, L ;
Bullrich, F ;
Fritz, LC ;
Trapani, JA ;
Tomaselli, KJ ;
Litwack, G ;
Alnemri, ES .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7464-7469
[9]   Dominant expression of a novel splice variant of caspase-8 in human peripheral blood lymphocytes [J].
Horiuchi, T ;
Himeji, D ;
Tsukamoto, H ;
Harashima, S ;
Hashimura, C ;
Hayashi, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 272 (03) :877-881
[10]   THE TNF RECEPTOR 1-ASSOCIATED PROTEIN TRADD SIGNALS CELL-DEATH AND NF-KAPPA-B ACTIVATION [J].
HSU, HL ;
XIONG, J ;
GOEDDEL, DV .
CELL, 1995, 81 (04) :495-504